A generic version of the Mirena intrauterine device (IUD) will likely be on the market by February 2015, according to doctors at the University of Cincinnati. The Mirena IUD is a hormonal birth control device manufactured by Bayer Pharmaceuticals, and has recently come under fire after thousands of patients have complained of Mirena side effects.
The Mirena IUD, which releases an artificial hormone known as progestrin, was originally approved by the U.S. Food and Drug Administration in 2000. In November 2010, Bayer received a warning from the FDA for using false and misleading information in advertising the device, as well as making unsubstantiated claims regarding its efficacy and downplaying the severe risks associated with Mirena.
Tens of thousands of women have since issued Mirena IUD side effects complaints to the FDA, including reports of internal bleeding, ectopic pregnancy and tissue damage when the device perforates the uterus and migrates through the body. Bayer faces thousands of Mirena IUD lawsuits alleging the company released a defective device.